Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Liu

Showing results (351-360 of 420) with videos related to

Pageof 42
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2019
AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent LymphomaJohn P Leonard, Marek Trneny, Koji Izutsu, et al.
Cold Spring Harbor Molecular Case Studies|March 17, 2017
An exome sequencing study of Moebius syndrome including atypical cases reveals an individual with CFEOM3A and a <i>TUBB3</i> mutationRonak M Patel, David Liu, Claudia Gonzaga-Jauregui, et al.
BMC Health Services Research|December 29, 2022
Baseline representativeness of patients in clinics enrolled in the PRimary care Opioid Use Disorders treatment (PROUD) trial: comparison of trial and non-trial clinics in the same health systemsPaige D Wartko, Hongxiang Qiu, Abisola E Idu, et al.
Lancet (London, England)|November 19, 2017
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trialJoshua D Lee, Edward V Nunes, Patricia Novo, et al.
Cell Reports|June 24, 2026
Recurrent ZC3H18 mutations stabilize oncogenic endogenous retroviral RNATanzina Tanu, Anna M Cox, Jennifer A Karlow, et al.
Cancer Research|May 11, 2017
Noninvasive Interrogation of DLL3 Expression in Metastatic Small Cell Lung CancerSai Kiran Sharma, Jacob Pourat, Dalya Abdel-Atti, et al.
American Journal of Hematology|February 19, 2019
Bone marrow biopsy in low-risk monoclonal gammopathy of undetermined significance reveals a novel smoldering multiple myeloma risk groupMark Bustoros, Efstathios Kastritis, Romanos Sklavenitis-Pistofidis, et al.
Journal of Consulting and Clinical Psychology|July 29, 2009
Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disordersDenise A Hien, Elizabeth A Wells, Huiping Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2020
T-Cell Infiltration and Adaptive Treg Resistance in Response to Androgen Deprivation With or Without Vaccination in Localized Prostate CancerAleksandar Z Obradovic, Matthew C Dallos, Marianna L Zahurak, et al.
Nature Communications|April 7, 2022
STAG2 regulates interferon signaling in melanoma via enhancer loop reprogrammingZhaowei Chu, Lei Gu, Yeguang Hu, et al.
Pageof 42

Showing results (351-360 of 420) with videos related to

Sort By:
Pageof 42
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2019
AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent LymphomaJohn P Leonard, Marek Trneny, Koji Izutsu, et al.
Cold Spring Harbor Molecular Case Studies|March 17, 2017
An exome sequencing study of Moebius syndrome including atypical cases reveals an individual with CFEOM3A and a <i>TUBB3</i> mutationRonak M Patel, David Liu, Claudia Gonzaga-Jauregui, et al.
BMC Health Services Research|December 29, 2022
Baseline representativeness of patients in clinics enrolled in the PRimary care Opioid Use Disorders treatment (PROUD) trial: comparison of trial and non-trial clinics in the same health systemsPaige D Wartko, Hongxiang Qiu, Abisola E Idu, et al.
Lancet (London, England)|November 19, 2017
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trialJoshua D Lee, Edward V Nunes, Patricia Novo, et al.
Cell Reports|June 24, 2026
Recurrent ZC3H18 mutations stabilize oncogenic endogenous retroviral RNATanzina Tanu, Anna M Cox, Jennifer A Karlow, et al.
Cancer Research|May 11, 2017
Noninvasive Interrogation of DLL3 Expression in Metastatic Small Cell Lung CancerSai Kiran Sharma, Jacob Pourat, Dalya Abdel-Atti, et al.
American Journal of Hematology|February 19, 2019
Bone marrow biopsy in low-risk monoclonal gammopathy of undetermined significance reveals a novel smoldering multiple myeloma risk groupMark Bustoros, Efstathios Kastritis, Romanos Sklavenitis-Pistofidis, et al.
Journal of Consulting and Clinical Psychology|July 29, 2009
Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disordersDenise A Hien, Elizabeth A Wells, Huiping Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2020
T-Cell Infiltration and Adaptive Treg Resistance in Response to Androgen Deprivation With or Without Vaccination in Localized Prostate CancerAleksandar Z Obradovic, Matthew C Dallos, Marianna L Zahurak, et al.
Nature Communications|April 7, 2022
STAG2 regulates interferon signaling in melanoma via enhancer loop reprogrammingZhaowei Chu, Lei Gu, Yeguang Hu, et al.
Pageof 42